BVT Aktienanleihe MOR 18.12.2024/ DE000VM6L1E6 /
23/05/2024 10:35:50 | Diferencia-0.090 | Bid10:35:50 | Ask10:35:50 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
104.510EUR | -0.09% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
MORPHOSYS AG O.N. | 13.66 - | 18/12/2024 | Call |
GlobeNewswire
13:02
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
13:00
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire
13:00
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire
13:00
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
13:00
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire
13:00
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire
13:00
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire
13:00
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire
13:00
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire
13:00
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página